Regor Therapeutics raises $90m for CARD platform in Series B funding round
Regor Therapeutics has raised $90 million in a Series B financing round towards the discovery and development of discovery of drugs for cancer, immune disorders, and metabolic diseases by leveraging its Computer Accelerated Rational Discovery platform (CARD platform). Lilly Asia Ventures led the Series B round of the clinical stage biotechnology company, which was established in July […]
